The Healthcare Businesswomen’s Association (HBA), a global not-for-profit organization dedicated to furthering the advancement and impact of women in the business of healthcare, points to a paper recently published by McKinsey, it’s annual Women in the Workplace study. Data from the study looks deeper into how women fare on compensation, promotion rates, and positions compared to peers in other industry segments.
Overall, the news is favorable for women in the business of healthcare-including those working in pharma, medical devices, and biotech.
Key takeaways from the McKinsey report include:
You can read the full Women in the Healthcare Industry report here.
What Every Pharma CEO Should Know About Unlocking the Potential of Scientific Data
December 11th 2024When integrated into pharmaceutical enterprises, scientific data has the potential to drive organizational growth and innovation. Mikael Hagstroem, CEO at leading laboratory informatics provider LabVantage Solutions, discusses how technology partners add significant value to pharmaceutical R&D, in addition to manufacturing quality.
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.